Skip to Main content Skip to Navigation
Journal articles

Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives

Abstract : This review aims to synthesize all the available data on brain molecular imaging, such as single-photon emission computed tomography (SPECT) and interictal fluorodeoxyglucose positron emission tomography (FDG-PET), in focal epilepsies. SPECT imaging is able to measure regional cerebral blood flow and its major innovation remains its ictal imaging value. On the other hand, FDG-PET, which has higher spatial resolution and lower background activity than SPECT, enables glycolytic metabolism to be identified in interictal states. Therefore, interictal FDG-PET has greater sensitivity than interictal SPECT, especially in temporal lobe epilepsies (TLEs). Thus, 18F-FDG-PET is a necessary step in the presurgical evaluation of TLEs, but also of extratemporal epilepsies (ETEs), contributing to > 30% of the decision to undertake surgery. In addition, FDG-PET has particular diagnostic value in focal epilepsies showing normal magnetic resonance imaging (MRI). PET also has good prognostic value for post-surgical outcomes as well as cognitive impairment, especially in cases where the hypometabolism extent is limited. Moreover, the notion of an epileptic network is well highlighted by functional PET imaging, allowing better understanding of the pathological substrates of these disorders. Future development of quantitative analysis software and of novel radiotracers and cameras will certainly enhance its clinical usefulness.
Complete list of metadatas

Cited literature [119 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-02479834
Contributor : Eric Guedj <>
Submitted on : Tuesday, April 21, 2020 - 11:37:43 AM
Last modification on : Thursday, November 19, 2020 - 2:50:08 PM

File

Brain molecular imaging in pha...
Files produced by the author(s)

Identifiers

Citation

A. Verger, S. Lagarde, L. Maillard, Fabrice Bartolomei, Eric Guedj. Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives. Revue Neurologique, Elsevier Masson, 2018, 174 (1-2), pp.16-27. ⟨10.1016/j.neurol.2017.05.001⟩. ⟨hal-02479834⟩

Share

Metrics

Record views

478

Files downloads

335